Issue 13, 2025

Photodynamic therapy with photodegradable photosensitizers

Abstract

Photodegradable photosensitizers have gained significant attention in recent years due to their potential advantages in photodynamic therapy. By degrading upon light exposure, these photosensitizers reduce post-treatment drug residues, minimize toxicity, and enhance the safety and precision of therapy. This review provides an overview of the design and current applications of photodegradable photosensitizers, addressing challenges related to light absorption efficiency, toxicity of degradation products, and tissue penetration. Furthermore, future optimization strategies, including chemical modifications, nanocarrier integration, and combination therapies, are discussed.

Graphical abstract: Photodynamic therapy with photodegradable photosensitizers

Article information

Article type
Highlight
Submitted
29 Sep 2024
Accepted
08 Jan 2025
First published
09 Jan 2025

Chem. Commun., 2025,61, 2627-2635

Photodynamic therapy with photodegradable photosensitizers

H. Wu, Y. Zhang, L. Jiang and H. Huang, Chem. Commun., 2025, 61, 2627 DOI: 10.1039/D4CC05091F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements